Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
JIM CRAMER
Tesla and the Market: Cramer's 'Mad Money' Recap (Thursday 10/22/20)
By Scott Rutt
Oct 22, 2020 9:26 PM EDT
PRESS RELEASES
Royalty Pharma Acquires Royalty Interest In Seltorexant From Minerva Neurosciences
By GlobeNewswire
Jan 19, 2021 8:30 AM EST
PRESS RELEASES
Royalty Pharma To Present At The J.P. Morgan Healthcare Conference On January 12
By GlobeNewswire
Jan 7, 2021 4:15 PM EST
PRESS RELEASES
Royalty Pharma Announces Charitable Gifts To Support COVID-19 Research At Leading Hospitals And Universities
By GlobeNewswire
Dec 22, 2020 8:30 AM EST
PRESS RELEASES
Royalty Pharma Announces Expansion Of Leadership Team
By GlobeNewswire
Dec 21, 2020 8:12 AM EST
PRESS RELEASES
Royalty Pharma Acquires Additional Royalty Interest From The Cystic Fibrosis Foundation
By GlobeNewswire
Nov 2, 2020 7:30 AM EST
JIM CRAMER
Tesla and the Market: Cramer's 'Mad Money' Recap (Thursday 10/22/20)
By Scott Rutt
Oct 22, 2020 9:26 PM EDT
PRESS RELEASES
Royalty Pharma Announces Closing Of Secondary Offering Of Class A Ordinary Shares By Selling Shareholders
By GlobeNewswire
Oct 20, 2020 4:32 PM EDT
PRESS RELEASES
Royalty Pharma To Announce Third-Quarter 2020 Financial Results On November 11, 2020
By GlobeNewswire
Oct 19, 2020 9:00 AM EDT
PRESS RELEASES
Royalty Pharma Announces Pricing Of Secondary Offering Of Class A Ordinary Shares By Selling Shareholders
By GlobeNewswire
Oct 15, 2020 11:45 PM EDT
PRESS RELEASES
Royalty Pharma Declares Fourth-Quarter 2020 Dividend
By GlobeNewswire
Oct 15, 2020 9:15 AM EDT
PRESS RELEASES
Royalty Pharma Announces Secondary Offering Of Class A Ordinary Shares By Selling Shareholders
By GlobeNewswire
Oct 13, 2020 4:10 PM EDT
PRESS RELEASES
Royalty Pharma Announces Closing Of $6.0 Billion Senior Unsecured Notes
By GlobeNewswire
Sep 2, 2020 4:25 PM EDT
PRESS RELEASES
Royalty Pharma Declares Third-Quarter 2020 Dividend
By GlobeNewswire
Sep 2, 2020 8:00 AM EDT
PRESS RELEASES
Royalty Pharma Announces Launch Of Senior Notes Offering
By GlobeNewswire
Aug 19, 2020 9:00 AM EDT
JIM CRAMER
Small Biz Woes: Cramer's 'Mad Money' Recap (Monday 8/17/20)
By Scott Rutt
Aug 17, 2020 11:47 PM EDT
PRESS RELEASES
Biohaven And Royalty Pharma Announce Funding Agreement Totaling Up To $450 Million
By GlobeNewswire
Aug 7, 2020 9:40 AM EDT
PRESS RELEASES
Royalty Pharma Appoints Henry A. Fernandez And Ted W. Love, M.D. To The Company's Board Of Directors
By GlobeNewswire
Aug 3, 2020 4:15 PM EDT
PRESS RELEASES
Royalty Pharma To Announce Second-Quarter 2020 Financial Results On August 12
By GlobeNewswire
Jul 20, 2020 4:15 PM EDT
PRESS RELEASES
Royalty Pharma Acquires Royalty Interest In Risdiplam From PTC Therapeutics
By GlobeNewswire
Jul 20, 2020 7:45 AM EDT
INVESTING
Albertsons IPO Is Priced at $16 in Scaled Back Listing
By Joseph Woelfel
Jun 26, 2020 8:54 AM EDT
PRESS RELEASES
Royalty Pharma Announces Closing Of Initial Public Offering
By GlobeNewswire
Jun 18, 2020 4:15 PM EDT
JIM CRAMER
Live With It: Cramer's 'Mad Money' Recap (Wednesday 6/17/20)
By Scott Rutt
Jun 17, 2020 9:44 PM EDT
INVESTING
Royalty Pharma Stock Soars in Year's Largest Debut
By Rob Lenihan
Jun 16, 2020 1:51 PM EDT
INVESTING
Royalty Pharma Raises $2.2B in Initial Public Offering
By Rob Lenihan
Jun 16, 2020 9:00 AM EDT
